Edwards Lifesciences Corporation Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax
Edwards Lifesciences Corporation (EW) reported Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax of $15.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Notes
us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax · last filed 2026-05-06
- Edwards Lifesciences Corporation reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2026-03-31 was $15.20M, a 47.40% decline year-over-year.
- Edwards Lifesciences Corporation reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2025-09-30 was $15.50M, a 20.10% decline year-over-year.
- Edwards Lifesciences Corporation reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2025-06-30 was $31.40M, a 136.09% increase year-over-year.
- Edwards Lifesciences Corporation reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2025-03-31 was $28.90M, a 351.56% increase year-over-year.
- Edwards Lifesciences Corporation reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2018 was -$15.30M, a 280.00% decline from fiscal 2017.
- Edwards Lifesciences Corporation reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2017 was $8.50M, a 23.19% increase from fiscal 2016.
- Edwards Lifesciences Corporation reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2016 was $6.90M, a 89.50% decline from fiscal 2015.
- Edwards Lifesciences Corporation reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2015 was $65.70M, a 838.57% increase from fiscal 2014.
| Period end | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 3 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 6 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 9 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $15.20M 10-Q · filed 2026-05-06 | |||
| 2025-09-30 | $15.50M 10-Q · filed 2025-11-05 | $46.90M derived: sum of 2 quarters · filed 2025-11-05 | $75.80M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2025-06-30 | $31.40M 10-Q · filed 2025-11-05 | $60.30M derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2025-03-31 | $28.90M 10-Q · filed 2026-05-06 | |||
| 2024-09-30 | $19.40M 10-Q · filed 2025-11-05 | $32.70M derived: sum of 2 quarters · filed 2025-11-05 | $39.10M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $13.30M 10-Q · filed 2025-11-05 | $19.70M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $6.40M 10-Q · filed 2025-11-05 | |||
| 2019-09-30 | $35.70M 10-Q · filed 2019-10-25 | |||
| 2019-03-31 | $8.60M 10-Q · filed 2019-04-26 | $18.10M derived: sum of 2 quarters · filed 2019-04-26 | $12.50M derived: sum of 3 quarters · filed 2019-04-26 | -$2.10M derived: sum of 4 quarters · filed 2019-04-26 |
| 2018-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $3.90M derived: sum of 2 quarters · filed 2019-02-15 | -$10.70M derived: sum of 3 quarters · filed 2019-02-15 | -$15.30M 10-K · filed 2019-02-15 |
| 2018-09-30 | -$5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | -$20.20M derived: sum of 2 quarters · filed 2018-10-26 | -$24.80M 10-Q · filed 2018-10-26 | -$22.00M derived: sum of 4 quarters · filed 2019-02-15 |
| 2018-06-30 | -$14.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$19.20M 10-Q · filed 2018-07-27 | -$16.40M derived: sum of 3 quarters · filed 2019-02-15 | -$14.80M derived: sum of 4 quarters · filed 2019-02-15 |
| 2018-03-31 | -$4.60M 10-Q · filed 2018-04-27 | -$1.80M derived: sum of 2 quarters · filed 2019-02-15 | -$200.00K derived: sum of 3 quarters · filed 2019-02-15 | $1.80M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $4.40M derived: sum of 2 quarters · filed 2019-02-15 | $6.40M derived: sum of 3 quarters · filed 2019-02-15 | $8.50M 10-K · filed 2019-02-15 |
| 2017-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $3.60M derived: sum of 2 quarters · filed 2017-10-27 | $5.70M 10-Q · filed 2017-10-27 | $2.50M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $4.10M 10-Q · filed 2017-07-28 | $900.00K derived: sum of 3 quarters · filed 2019-02-15 | |
| 2017-03-31 | $2.10M 10-Q · filed 2017-04-28 | -$1.10M derived: sum of 2 quarters · filed 2019-02-15 | ||
| 2016-12-31 | -$3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $6.90M 10-K · filed 2019-02-15 | ||
| 2016-09-30 | $10.10M 10-Q · filed 2016-10-28 | |||
| 2015-12-31 | $16.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $36.60M derived: sum of 2 quarters · filed 2018-02-16 | $55.40M derived: sum of 3 quarters · filed 2018-02-16 | $65.70M 10-K · filed 2018-02-16 |
| 2015-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $38.80M derived: sum of 2 quarters · filed 2015-10-29 | $49.10M 10-Q · filed 2015-10-29 | $51.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2015-06-30 | $18.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $29.10M 10-Q · filed 2015-07-29 | $31.00M derived: sum of 3 quarters · filed 2016-02-19 | $28.40M derived: sum of 4 quarters · filed 2016-02-19 |
| 2015-03-31 | $10.30M 10-Q · filed 2015-04-29 | $12.20M derived: sum of 2 quarters · filed 2016-02-19 | $9.60M derived: sum of 3 quarters · filed 2016-02-19 | $12.30M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$700.00K derived: sum of 2 quarters · filed 2016-02-19 | $2.00M derived: sum of 3 quarters · filed 2016-02-19 | $7.00M 10-K · filed 2016-02-19 |
| 2014-09-30 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $100.00K derived: sum of 2 quarters · filed 2014-10-31 | $5.10M 10-Q · filed 2014-10-31 | $7.30M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $7.70M 10-Q · filed 2014-08-04 | $9.90M derived: sum of 3 quarters · filed 2016-02-19 | |
| 2014-03-31 | $5.00M 10-Q · filed 2014-05-02 | $7.20M derived: sum of 2 quarters · filed 2016-02-19 | ||
| 2013-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $20.50M 10-K · filed 2016-02-19 | ||
| 2013-09-30 | $18.30M 10-Q · filed 2013-11-07 | |||
| 2012-12-31 | $11.30M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | -$27.70M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |